In this unrivalled COVID 19 crisis, we are surrounded by frenzied watsapp messages, scrap of pandemic wisdom and never ending stream of Calls. Finding Some hope and positively in this time has been tough.
The future for PCD Pharma portfolio Companies has been quite predictable but its not the time to lose hope and sanity. Every Crisis comes with someone unseen, unpredictable opportunities and also test the limit of our resilience. The Businesses has been zero due to COVID 19 Lockdown . This is the time to make decision wisely specially while making cost reduction measures.
We need to look at the reality that despite lockdown Pharma market grows by 9% in March due to painic buying. Pharma PCD Companies need to plan their stocks very wisely. Demand for chronic disease like Cardiac-Diabetic therapy drugs and respiratory medicine saw a specular hike in buying due to lockdown. Cardiac therapy medicine & Anti diabetic drugs sale increase by 8.9%, where respiratory medicine sale saw spark spike of 23% than february. But on the other demand for Gynaecology, Derma and Vaccines dropped drastically than last month.
Use this time to up your career and Business skills. Provide online training to your employee, encourage them to work online. Bring your Business Online and develop long lastic relations with your Customers. Plan a strong Digital presense of your brand, product and services. B2B E-commerce is the future of medicine wholesale buying & Supplies. B2B Pharma Marketplace startup’s like PharmaFlair are playing a major role by providing a platform for independent Pharmacies, PCD Franchisors, Stockists, Distributor’s to connect and online buy medicine in wholesale from the best Pharma wholesale manufacturers, Suppliers & Traders Globally.